The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Sp210
THERAPEUTIC POTENTIAL OF MICROBIOTA DERIVED AHR LIGANDS IN IBD
Date
May 6, 2023
Explore related products in the following collection:
The role of nutrition and the microbiome is evident in IBD and functional bowel disorders. The microbiome can affect the way nutrients are metabolized in bioactive components. It is of important to understand the molecular sensors of such metabolized components. Tryptophan is known to mediate Indole derivatives and other molecules that activate a nuclear receptor Aryl Hydrocarbon Receptor. Recently, many advances were made in relating tryptophan and its metabolites to a variety of inflammatory and functional disorders. The session brings together specialists in the field that work on AhR signaling in IBD, IBS, Celiac disease and cancer, to review current strategies to understand tryptophan metabolites and potentially harness nutritional support of disease states.
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
BACKGROUND: Enterochromaffin cells (ECs) are specialized gastrointestinal (GI) epithelial cells that transduce luminal forces and chemicals into release of signal molecules including serotonin (5-HT) to alter GI function including mucosal ion transport…